BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 33838012)

  • 1. Economic evaluation of differentiated service delivery models for HIV treatment in Lesotho: costs to providers and patients.
    Nichols BE; Cele R; Lekodeba N; Tukei B; Ngorima-Mabhena N; Tiam A; Maotoe T; Sejana MV; Faturiyele IO; Chasela C; Rosen S; Fatti G
    J Int AIDS Soc; 2021 Apr; 24(4):e25692. PubMed ID: 33838012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness and cost-effectiveness of 3- vs. 6-monthly dispensing of antiretroviral treatment (ART) for stable HIV patients in community ART-refill groups in Zimbabwe: study protocol for a pragmatic, cluster-randomized trial.
    Fatti G; Ngorima-Mabhena N; Chirowa F; Chirwa B; Takarinda K; Tafuma TA; Mahachi N; Chikodzore R; Nyadundu S; Ajayi CA; Mutasa-Apollo T; Mugurungi O; Mothibi E; Hoffman RM; Grimwood A
    Trials; 2018 Jan; 19(1):79. PubMed ID: 29378662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VIBRA trial - Effect of village-based refill of ART following home-based same-day ART initiation vs clinic-based ART refill on viral suppression among individuals living with HIV: protocol of a cluster-randomized clinical trial in rural Lesotho.
    Amstutz A; Lejone TI; Khesa L; Muhairwe J; Nsakala BL; Tlali K; Bresser M; Tediosi F; Kopo M; Kao M; Klimkait T; Battegay M; Glass TR; Labhardt ND
    Trials; 2019 Aug; 20(1):522. PubMed ID: 31439004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The costs of providing antiretroviral therapy services to HIV-infected individuals presenting with advanced HIV disease at public health centres in Dar es Salaam, Tanzania: Findings from a randomised trial evaluating different health care strategies.
    Kimaro GD; Mfinanga S; Simms V; Kivuyo S; Bottomley C; Hawkins N; Harrison TS; Jaffar S; Guinness L;
    PLoS One; 2017; 12(2):e0171917. PubMed ID: 28234969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varying intervals of antiretroviral medication dispensing to improve outcomes for HIV patients (The INTERVAL Study): study protocol for a randomized controlled trial.
    Hoffman R; Bardon A; Rosen S; Fox M; Kalua T; Xulu T; Taylor A; Sanne I
    Trials; 2017 Oct; 18(1):476. PubMed ID: 29029644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can differentiated care models solve the crisis in HIV treatment financing? Analysis of prospects for 38 countries in sub-Saharan Africa.
    Barker C; Dutta A; Klein K
    J Int AIDS Soc; 2017 Jul; 20(Suppl 4):21648. PubMed ID: 28770597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-month prescriptions, fast-track refills, and community ART groups: results from a process evaluation in Malawi on using differentiated models of care to achieve national HIV treatment goals.
    Prust ML; Banda CK; Nyirenda R; Chimbwandira F; Kalua T; Jahn A; Eliya M; Callahan K; Ehrenkranz P; Prescott MR; McCarthy EA; Tagar E; Gunda A
    J Int AIDS Soc; 2017 Jul; 20(Suppl 4):21650. PubMed ID: 28770594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost and cost-effectiveness of switching from d4T or AZT to a TDF-based first-line regimen in a resource-limited setting in rural Lesotho.
    Jouquet G; Bygrave H; Kranzer K; Ford N; Gadot L; Lee J; Hilderbrand K; Goemaere E; Vlahakis N; Trivino L; Makakole L; Cleary S
    J Acquir Immune Defic Syndr; 2011 Nov; 58(3):e68-74. PubMed ID: 21765366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Client and provider preferences for HIV care: Implications for implementing differentiated service delivery in Thailand.
    Lujintanon S; Amatavete S; Sungsing T; Seekaew P; Peelay J; Mingkwanrungruang P; Chinbunchorn T; Teeratakulpisarn S; Methajittiphan P; Leenasirima P; Norchaiwong A; Nilmanat A; Phanuphak P; Ramautarsing RA; Phanuphak N
    J Int AIDS Soc; 2021 Apr; 24(4):e25693. PubMed ID: 33792192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ART treatment costs and retention in care in Kenya: a cohort study in three rural outpatient clinics.
    Larson BA; Bii M; Henly-Thomas S; McCoy K; Sawe F; Shaffer D; Rosen S
    J Int AIDS Soc; 2013 Jan; 16(1):18026. PubMed ID: 23305696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annual cost of antiretroviral therapy among three service delivery models in Uganda.
    Vu L; Waliggo S; Zieman B; Jani N; Buzaalirwa L; Okoboi S; Okal J; Borse NN; Kalibala S
    J Int AIDS Soc; 2016; 19(5 Suppl 4):20840. PubMed ID: 27443270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-Effectiveness and Budget Impact Analysis of the Implementation of Differentiated Service Delivery Models for HIV Treatment in Mozambique: a Modelling Study.
    Moiana Uetela DA; Zimmermann M; Chicumbe S; Gudo ES; Barnabas R; Uetela OA; Dinis A; Augusto O; Gaveta S; Couto A; Gaspar I; Macul H; Hughes JP; Gimbel S; Sherr K
    J Int AIDS Soc; 2024 May; 27(5):e26275. PubMed ID: 38801731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retention in care, resource utilization, and costs for adults receiving antiretroviral therapy in Zambia: a retrospective cohort study.
    Scott CA; Iyer HS; McCoy K; Moyo C; Long L; Larson BA; Rosen S
    BMC Public Health; 2014 Mar; 14():296. PubMed ID: 24684772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Same day ART initiation versus clinic-based pre-ART assessment and counselling for individuals newly tested HIV-positive during community-based HIV testing in rural Lesotho - a randomized controlled trial (CASCADE trial).
    Labhardt ND; Ringera I; Lejone TI; Masethothi P; Thaanyane T; Kamele M; Gupta RS; Thin K; Cerutti B; Klimkait T; Fritz C; Glass TR
    BMC Public Health; 2016 Apr; 16():329. PubMed ID: 27080120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the cost of providing outpatient HIV counseling and testing and antiretroviral therapy services in selected public health facilities in Nigeria?
    Aliyu HB; Chuku NN; Kola-Jebutu A; Abubakar Z; Torpey K; Chabikuli ON
    J Acquir Immune Defic Syndr; 2012 Oct; 61(2):221-5. PubMed ID: 22820805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Funding antiretroviral treatment for HIV-positive temporary residents in Australia prevents transmission and is inexpensive.
    Gray RT; Watson J; Cogle AJ; Smith DE; Hoy JF; Bastian LA; Finlayson R; Drummond FM; Whittaker B; Law MG; Petoumenos K
    Sex Health; 2018 Feb; 15(1):13-19. PubMed ID: 28874236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Offering Same-Day ART vs Usual Health Facility Referral During Home-Based HIV Testing on Linkage to Care and Viral Suppression Among Adults With HIV in Lesotho: The CASCADE Randomized Clinical Trial.
    Labhardt ND; Ringera I; Lejone TI; Klimkait T; Muhairwe J; Amstutz A; Glass TR
    JAMA; 2018 Mar; 319(11):1103-1112. PubMed ID: 29509839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of community health worker-led home delivery of antiretroviral therapy on virological suppression: a non-inferiority cluster-randomized health systems trial in Dar es Salaam, Tanzania.
    Geldsetzer P; Francis JM; Ulenga N; Sando D; Lema IA; Mboggo E; Vaikath M; Koda H; Lwezaula S; Hu J; Noor RA; Olofin I; Larson E; Fawzi W; Bärnighausen T
    BMC Health Serv Res; 2017 Feb; 17(1):160. PubMed ID: 28228134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimated Costs for Delivery of HIV Antiretroviral Therapy to Individuals with CD4+ T-Cell Counts >350 cells/uL in Rural Uganda.
    Jain V; Chang W; Byonanebye DM; Owaraganise A; Twinomuhwezi E; Amanyire G; Black D; Marseille E; Kamya MR; Havlir DV; Kahn JG
    PLoS One; 2015; 10(12):e0143433. PubMed ID: 26632823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapy.
    Freedberg KA; Kumarasamy N; Losina E; Cecelia AJ; Scott CA; Divi N; Flanigan TP; Lu Z; Weinstein MC; Wang B; Ganesh AK; Bender MA; Mayer KH; Walensky RP
    AIDS; 2007 Jul; 21 Suppl 4(Suppl 4):S117-28. PubMed ID: 17620747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.